ArticleInternational journal of molecular sciences2022

Evaluation of the Sensitivity of Breast Cancer Cell Lines to Cardiac Glycosides Unveils ATP1B3 as a Possible Biomarker for the Personalized Treatment of ERα Expressing Breast Cancers.

Filippo AcconciaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.